Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilsartan vs Losartan in Diabetic Kidney Disease and Hypertension
NCT05753696Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Apr 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of azilsartan in diabetic kidney disease (DKD) and hypertension (HTN) (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Proteinuria at 16 weeks. Status: unknown.
02
Drugs
azilsartan
03
Conditions
diabetic kidney disease (DKD)hypertension (HTN)
Beyond the preview
Go deeper on NCT05753696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05753696.